The role of microparticles in inhibiting hypoxia and serum deprivation induced apoptosis of bone marrow mesenchymal stem cells
JIN Peifeng1, JIANG Sheng1, WENG Jiakan1,2, WANG Lei1, Ding Lu3, ZHAO Kaixiang1, SUN Chengchao1
1.Department of Cardiothoracic Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China; 2.Department of Cardiothoracic Surgery, Sir Run Run Shaw Hospital, Affiliated to Zhejiang University School of Medicine, Hangzhou 310000, China; 3.Department of Ergology, Wenzhou Medical University, Wenzhou 325035, China
JIN Peifeng1,JIANG Sheng,WENG Jiakan, et al. The role of microparticles in inhibiting hypoxia and serum deprivation induced apoptosis of bone marrow mesenchymal stem cells[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2019, 49(2): 79-84.
Abstract:Objective: To investigate the effects of myocardial infarction plasma-derived microparticles (MPs) on the hypoxia and serum deprivation induced apoptosis of bone marrow mesenchymal stem cells (BMSCs). Methods: Myocardial infarction (MI) was created by left anterior descending artery ligation in Lewis rats. The plasma-derived MPs were isolated 24 hours later from the blood. In order to study the protective effects of MPs on BMSCs under the conditions of hypoxia and serum deprivation (hypoxia/SD). BMSCs were pretreated with different concentrations (0.5 μg/mL, 1 μg/mL, and 2 μg/mL) of MPs before the apoptosis was induced. Cell apoptosis was evaluated by using flow cytometry of Annexin V/PI staining, Hoechst staining and the Tunel assay. Expression of cleavage of caspase-3 were assessed by Western blotting. The Akt pathway inhibitor AZD5363 was used to reveal the mechanism of MPs inhibiting BMSCs apoptosis. Results: The MPs derived from the myocardial infarction rats could remarkably prevent BMSCs from Hypoxia/SD induced apoptosis through activating Akt signaling pathway, and its anti-apoptosis effect showed a concentration dependence (0.5-2 μg/mL) (P<0.01). Conclusion: MPs derived from myocardial infarction could effectively inhibit hypoxia/SD induced apoptosis of BMSCs.
[1] JIN P, WANG E, WANG Y H, et al. Central zone of myocardial infarction: a neglected target area for heart cell therapy [J]. J Cell Mol Med, 2012, 16 (3): 637-648.
[2] RODRIGO S F, MANN I, RAMSHORST J VAN, et al. Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: long-term results[J]. J Interv Cardiol, 2017, 30(5): 440-447.
[3] CHEN Y, ZHAO Y, CHEN W, et al. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction[J]. Stem Cell Res Ther, 2017, 8(1): 268.
[4] RAPOSO G, STOORVOGEL W. Extracellular vesicles: exosomes, microvesicles, and friends[J]. J Cell Biol, 2013, 200(4): 373-383.
[5] BENAMEUR T, ANDRIANTSITOHAINA R, MARTINEZ M C. Therapeutic potential of plasma membrane-derived microparticles[J]. Pharmacol Rep, 2009, 61(1): 49-57.
[6] 金培峰, 张浩, 陆地, 等. 雪旺细胞移植改善心肌梗死后副交感/交感神经重塑[J]. 温州医科大学学报, 2016, 46(1): 13-18.
[7] SIONIS A, SUADES R, SANS-ROSELLO J, et al. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock[J]. Int J Cardiol, 2018, 258: 249-256.
[8] 陈棉, 王珏, 耿志敏, 等. 骨髓间充质干细胞条件膜微粒对心脏成纤维细胞的影响[J]. 温州医科大学学报, 2016, 46(9): 625-628.
[9] BERNAL-MIZRACHI L, JY W, JIMENEZ J J, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes[J]. Am Heart J, 2003, 145 (6): 962-970.
[10] GHOLAMIN S, PASDAR A, KHORRAMI M S, et al. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment[J]. Curr Pharm Des, 2016, 22(3): 397-403.
[11] QUESENBERRY P J, ALIOTTA J M. Cellular phenotype switching and microvesicles[J]. Adv Drug Deliv Rev, 2010, 62(12): 1141-1148.
[12] QUESENBERRY P J, DOONER M S, ALIOTTA J M. Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles[J]. Exp Hematol, 2010, 38(7): 581-592.